Results from a Phase 3 Study of Once-Monthly Aripiprazole Intramuscular (IM ... - MarketWatch (press release)
SunHerald.
Results from a Phase 3 Study of Once-Monthly Aripiprazole Intramuscular (IM ... - EON: Enhanced Online News (press release)
Results from a Phase 3 Study of Once-Monthly Aripiprazole Intramuscular (IM .
Long-term Injectable Drug Effective for Schizophrenia - Medscape
Long-term Injectable Drug Effective for SchizophreniaMedscapeMay 11, 2012 (Philadelphia, Pennsylvania) — Intramuscular depot aripiprazole is a safe and tolerable option for long-term maintenance treatment of schizophrenia, according to several presentations from a new large trial presented here at the American .
Court Report - Patent Docs
Court ReportPatent Docs6977257 ('Aripiprazole Oral Solution,' issued December 20, 2005) following a Paragraph IV certification as part of Amneal's filing of an ANDA to manufacture a generic version of Otsuka's Abilify® (aripiprazole, used to treat bipolar disorder and .
Abilify Does Well in Depot Version - MedPage Today
Abilify Does Well in Depot VersionMedPage TodayNote that a phase III study was halted at a preplanned interim data point which demonstrated fewer relapses with depot aripiprazole compared with placebo for long-term maintenance in schizophrenia.
us